Wordt geladen...

Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311

C1311 is a novel therapeutic agent with potent activity against experimental colorectal cancer that has been selected for entry into clinical trial. The compound has previously been shown to have DNA-binding properties and to inhibit the catalytic activity of topoisomerase II. In this study, cellula...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Burger, A M, Jenkins, T C, Double, J A, Bibby, M C
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 1999
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362878/
https://ncbi.nlm.nih.gov/pubmed/10496367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690702
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!